We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the
The ICN also form part of other research structures such as the Centre for Networked Biomedical Research in Mental Health (CIBERSAM) and the Centre for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED).
Within the Hospital Clínic Neurosciences Institute there are multiple lines of research in which clinical and basic researchers, and researchers from the various disciplines that make up the Institute, work together and transversally. The Institute’s research aims to advance knowledge of the causes and prevention of the different diseases of the nervous system, as well as to improve treatment.
The Institute’s research focuses mainly on the following disorders and diseases: Depression, Bipolar Disorders, Schizophrenia, Addictive Behaviours, Gender Dysphoria, Personality Disorders, Autistic Spectrum Disorders, Obsessive Compulsive Disorder, Eating Disorders, Attention Deficit Hyperactivity Disorder, Brain Tumours, Brain Microsurgery, Stroke, Epilepsy, Multiple Sclerosis, Alzheimer’s Disease, Parkinson’s Disease, Pain and Sleep Disorders.
The body of research carried out by the various research groups has given rise to numerous publications with a significant international impact. Publications by the Institute’s researchers can be found on the lists of the most frequently quoted articles in the scientific literature. The researchers regularly attend highly prestigious national and international scientific congresses in the field of neuroscience as speakers and organizers. Some of the researchers are presidents, board members and scientific committee members of Catalan, Spanish, European and international medical associations. Also worthy of note is the high number of Catalan, Spanish and international research grants obtained by the Institute’s researchers. There is constant participation in clinical trials, especially those focused on the design of new drugs to improve patients’ quality of life.
The Institute’s research coordinator supervises the approval of different projects and each year organizes a research day at which some of the most important work carried out is presented.